Congressional Questionnaire

Prescription Justice Policy Platform Congressional Questionnaire

Prescription Justice is a non-profit organization dedicated to lowering drug prices in America. We are giving members of Congress the opportunity to state their positions on the Prescription Justice policy platform in support of the following:

Ending the ban that prevents Medicare from negotiating lower drug prices with pharmaceutical companies;
Making reverse payment arrangements between brand and generic companies illegal, also known as "pay-for-delay";
Ending "evergreening" practices, in which drug companies tweak the original drug to extend the patent;
Using trade agreements to improve, not hinder generic drug availability, with a focus on getting biosimilars to market faster;
Legalizing the importation of lower-cost medication from Canada and other countries with similarly strict pharmaceutical regulations; and
Using FDA enforcement discretion to permit individuals with valid prescriptions to import more affordable medication for personal use.

Chamber *

Name of Member of Congress *

Authorized Congressional Staff/Contact Person Filling Out Form *

Authorized Congressional Staff/Contact Person's Title *

Email Address for Authorized Congressional Staff/Contact Person *

Political Affiliation of the Member of Congress *

State *

Congressional District Number *

Phone Number *

Question 1. Do you agree with the following statement?

Covid-19 infuses the crisis of high drug prices with greater life and death urgency. The federal government should ensure that all Americans, regardless of their ability to pay, have access to all Covid-19 treatments and vaccines.

Q1 Answer *

Question 2.
Do you agree with the following statement?
The United States is suffering from a crisis of high drug prices.

Q2. Answer *

Question 3.
Which of the following legislative or federal policy positions do you support? Select all that apply.

Ending the ban that prevents Medicare from negotiating lower drug prices with pharmaceutical companies.

Making reverse payment arrangements between brand and generic companies illegal, also known as "pay-for-delay."

Ending “evergreening” practices, in which drug companies tweak the original drug to extend the patent.

Using trade agreements to improve not hinder generic drug availability, with a focus on getting biosimilars to market faster.

Legalizing the importation of lower-cost medication from Canada and other countries with similarly strict pharmaceutical regulations.

Using FDA enforcement discretion to permit individuals with valid prescriptions to import more affordable medication for personal use.

Question 4.
Your Comments on Drug Prices

You agree that you are authorized to fill out this form on behalf of the member of Congress identified above.

I am not a robot. *

Your questionnaire is not complete. A confirmation email will be sent to the specified email address. A copy of your questionnaire responses will be sent to your email address.

Stay informed about news and advocacy centered on the crisis of high drug prices